{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T20:40:57Z","timestamp":1784580057848,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-08066-z","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:56:21Z","timestamp":1746186981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["CD55 upregulation in T cells of COVID-19 patients suppresses type-I interferon responses"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4425-235X","authenticated-orcid":false,"given":"Maria G.","family":"Detsika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sakkou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassiliki","family":"Triantafyllidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2142-3021","authenticated-orcid":false,"given":"Dimitris","family":"Konstantopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Grigoriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherina","family":"Psarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7306-713X","authenticated-orcid":false,"given":"Edison","family":"Jahaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Dimopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stylianos E.","family":"Orfanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Tsirogianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1867-3150","authenticated-orcid":false,"given":"George","family":"Kollias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2508-500X","authenticated-orcid":false,"given":"Anastasia","family":"Kotanidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"8066_CR1","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/infdis\/jiaa646","volume":"223","author":"AH de Nooijer","year":"2021","unstructured":"de Nooijer, A. H. et al. Complement activation in the disease course of coronavirus disease 2019 and its effects on clinical outcomes.  J. Infect. Dis. 223, 214\u2013224 (2021).","journal-title":"J. Infect. Dis."},{"key":"8066_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.668725","volume":"12","author":"B Alosaimi","year":"2021","unstructured":"Alosaimi, B. et al. Complement anaphylatoxins and inflammatory cytokines as prognostic markers for COVID-19 severity and in-hospital mortality. Front. Immunol. 12, 668725 (2021).","journal-title":"Front. Immunol."},{"key":"8066_CR3","doi-asserted-by":"crossref","unstructured":"Detsika M. G. et al. C3a and C5b-9 differentially predict COVID-19 progression and outcome. Life 12, 1335 (2022).","DOI":"10.3390\/life12091335"},{"key":"8066_CR4","first-page":"1","volume":"220","author":"C Magro","year":"2020","unstructured":"Magro, C. et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl. Res. J. Lab. Clin. Med. 220, 1\u201313 (2020).","journal-title":"Transl. Res. J. Lab. Clin. Med."},{"key":"8066_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154519","volume":"247","author":"X Ge","year":"2023","unstructured":"Ge, X. et al. Complement and complement regulatory proteins are upregulated in lungs of COVID-19 patients. Pathol. Res. Pract. 247, 154519 (2023).","journal-title":"Pathol. Res. Pract."},{"key":"8066_CR6","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nri2620","volume":"9","author":"PF Zipfel","year":"2009","unstructured":"Zipfel, P. F. & Skerka, C. Complement regulators and inhibitory proteins. Nat. Rev. Immunol. 9, 729\u2013740 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"8066_CR7","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3389\/fimmu.2019.01074","volume":"10","author":"A Geller","year":"2019","unstructured":"Geller, A. & Yan, J. The role of membrane-bound complement regulatory proteins in tumor development and cancer immunotherapy. Front. Immunol. 10, 1074 (2019).","journal-title":"Front. Immunol."},{"key":"8066_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0162-3109(99)00005-3","volume":"42","author":"DE Hourcade","year":"1999","unstructured":"Hourcade, D. E., Mitchell, L. M. & Medof, M. E. Decay acceleration of the complement alternative pathway C3 convertase. Immunopharmacology 42, 167\u2013173 (1999).","journal-title":"Immunopharmacology"},{"key":"8066_CR9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1146\/annurev.iy.09.040191.002243","volume":"9","author":"MK Liszewski","year":"1991","unstructured":"Liszewski, M. K., Post, T. W. & Atkinson, J. P. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu. Rev. Immunol. 9, 431\u2013455 (1991).","journal-title":"Annu. Rev. Immunol."},{"key":"8066_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0065-2776(08)60654-9","volume":"46","author":"JM Ahearn","year":"1989","unstructured":"Ahearn, J. M. & Fearon, D. T. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv. Immunol. 46, 183\u2013219 (1989).","journal-title":"Adv. Immunol."},{"key":"8066_CR11","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1084\/jem.170.3.637","volume":"170","author":"A Davies","year":"1989","unstructured":"Davies, A. et al. CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.  J. Exp. Med. 170, 637\u2013654 (1989).","journal-title":"J. Exp. Med."},{"key":"8066_CR12","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","volume":"6","author":"NS Merle","year":"2015","unstructured":"Merle, N. S., Church, S. E., Fremeaux-Bacchi, V. & Roumenina, L. T. Complement system Part I - molecular mechanisms of activation and regulation. Front. Immunol. 6, 262 (2015).","journal-title":"Front. Immunol."},{"key":"8066_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3345\/kjp.2015.58.7.239","volume":"58","author":"H Cho","year":"2015","unstructured":"Cho, H. Complement regulation: physiology and disease relevance. Korean J. Pediatrics 58, 239\u2013244 (2015).","journal-title":"Korean J. Pediatrics"},{"key":"8066_CR14","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.4049\/jimmunol.1203487","volume":"190","author":"D Ricklin","year":"2013","unstructured":"Ricklin, D. & Lambris, J. D. Complement in immune and inflammatory disorders: pathophysiological mechanisms. J. Immunol. 190, 3831\u20133838 (2013).","journal-title":"J. Immunol."},{"key":"8066_CR15","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1084\/jem.20040863","volume":"201","author":"J Liu","year":"2005","unstructured":"Liu, J. et al. The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo.  J. Exp. Med. 201, 567\u2013577 (2005).","journal-title":"J. Exp. Med."},{"key":"8066_CR16","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/ni810","volume":"3","author":"JC Marie","year":"2002","unstructured":"Marie, J. C. et al. Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation. Nat. Immunol. 3, 659\u2013666 (2002).","journal-title":"Nat. Immunol."},{"key":"8066_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1290684","volume":"14","author":"FQ An","year":"2023","unstructured":"An, F. Q. et al. KLF4 and CD55 expression and function depend on each other. Front. Immunol. 14, 1290684 (2023).","journal-title":"Front. Immunol."},{"key":"8066_CR18","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1182\/blood-2006-12-063636","volume":"110","author":"X Zhang","year":"2007","unstructured":"Zhang, X. et al. Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood 110, 228\u2013236 (2007).","journal-title":"Blood"},{"key":"8066_CR19","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41591-021-01329-2","volume":"27","author":"E Stephenson","year":"2021","unstructured":"Stephenson, E. et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat. Med. 27, 904\u2013916 (2021).","journal-title":"Nat. Med."},{"key":"8066_CR20","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41591-020-0944-y","volume":"26","author":"AJ Wilk","year":"2020","unstructured":"Wilk, A. J. et al. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat. Med. 26, 1070\u20131076 (2020).","journal-title":"Nat. Med."},{"key":"8066_CR21","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718\u2013724 (2020).","journal-title":"Science"},{"key":"8066_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41590-020-00840-x","volume":"22","author":"IE Galani","year":"2021","unstructured":"Galani, I. E. et al. Untuned antiviral immunity in COVID-19 revealed by temporal type I\/III interferon patterns and flu comparison. Nat. Immunol. 22, 32\u201340 (2021).","journal-title":"Nat. Immunol."},{"key":"8066_CR23","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.humimm.2013.01.011","volume":"74","author":"J Nuutila","year":"2013","unstructured":"Nuutila, J. et al. Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infections. Hum. Immunol. 74, 522\u2013530 (2013).","journal-title":"Hum. Immunol."},{"key":"8066_CR24","doi-asserted-by":"publisher","first-page":"25018","DOI":"10.1073\/pnas.2010540117","volume":"117","author":"JC Holter","year":"2020","unstructured":"Holter, J. C. et al. Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients. Proc. Natl. Acad. Sci. USA 117, 25018\u201325025 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"8066_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.663187","volume":"12","author":"G Sinkovits","year":"2021","unstructured":"Sinkovits, G. et al. Complement overactivation and consumption predicts in-hospital mortality in SARS-CoV-2 infection. Front. Immunol. 12, 663187 (2021).","journal-title":"Front. Immunol."},{"key":"8066_CR26","doi-asserted-by":"crossref","unstructured":"Ma, L. et al. Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection. Sci. Immunol. 6, 2021.","DOI":"10.1126\/sciimmunol.abh2259"},{"key":"8066_CR27","doi-asserted-by":"crossref","unstructured":"Macor, P. et al. Multiple-organ complement deposition on vascular endothelium in COVID-19 patients. Biomedicines 9, 1003 (2021).","DOI":"10.3390\/biomedicines9081003"},{"key":"8066_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.815833","volume":"13","author":"SL Lage","year":"2022","unstructured":"Lage, S. L. et al. Activation of complement components on circulating blood monocytes from COVID-19 patients. Front. Immunol. 13, 815833 (2022).","journal-title":"Front. Immunol."},{"key":"8066_CR29","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jaci.2020.04.029","volume":"146","author":"S Trouillet-Assant","year":"2020","unstructured":"Trouillet-Assant, S. et al. Type I IFN immunoprofiling in COVID-19 patients.  J. Allergy Clin. Immunol. 146, 206\u2013208.e202 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"8066_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41421-020-00225-2","volume":"6","author":"G Xu","year":"2020","unstructured":"Xu, G. et al. The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing. Cell Discov. 6, 73 (2020).","journal-title":"Cell Discov."},{"key":"8066_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44524-0","volume":"15","author":"QXX Lin","year":"2024","unstructured":"Lin, Q. X. X. et al. Longitudinal single cell atlas identifies complex temporal relationship between type I interferon response and COVID-19 severity. Nat. Commun. 15, 567 (2024).","journal-title":"Nat. Commun."},{"key":"8066_CR32","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1084\/jem.20041967","volume":"201","author":"PS Heeger","year":"2005","unstructured":"Heeger, P. S. et al. Decay-accelerating factor modulates induction of T cell immunity.  J. Exp. Med. 201, 1523\u20131530 (2005).","journal-title":"J. Exp. Med."},{"key":"8066_CR33","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.4049\/jimmunol.179.5.3178","volume":"179","author":"C Fang","year":"2007","unstructured":"Fang, C., Miwa, T., Shen, H. & Song, W. C. Complement-dependent enhancement of CD8+ T cell immunity to lymphocytic choriomeningitis virus infection in decay-accelerating factor-deficient mice. J. Immunol. 179, 3178\u20133186 (2007).","journal-title":"J. Immunol."},{"key":"8066_CR34","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1182\/blood-2011-04-348474","volume":"118","author":"C Fang","year":"2011","unstructured":"Fang, C., Miwa, T. & Song, W. C. Decay-accelerating factor regulates T-cell immunity in the context of inflammation by influencing costimulatory molecule expression on antigen-presenting cells. Blood 118, 1008\u20131014 (2011).","journal-title":"Blood"},{"key":"8066_CR35","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.4049\/jimmunol.149.6.2055","volume":"149","author":"RW Finberg","year":"1992","unstructured":"Finberg, R. W., White, W. & Nicholson-Weller, A. Decay-accelerating factor expression on either effector or target cells inhibits cytotoxicity by human natural killer cells. J. Immunol. 149, 2055\u20132060 (1992).","journal-title":"J. Immunol."},{"key":"8066_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e25090","volume":"10","author":"R Bali Swain","year":"2024","unstructured":"Bali Swain, R., Lin, X. & Wallentin, F. Y. COVID-19 pandemic waves: identification and interpretation of global data. Heliyon 10, e25090 (2024).","journal-title":"Heliyon"},{"key":"8066_CR37","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cels.2018.11.005","volume":"8","author":"SL Wolock","year":"2019","unstructured":"Wolock, S. L., Lopez, R. & Klein, A. M. Scrublet: computational identification of cell doublets in single-cell transcriptomic data. Cell Syst. 8, 281\u2013291.e289 (2019).","journal-title":"Cell Syst."},{"key":"8066_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1382-0","volume":"19","author":"FA Wolf","year":"2018","unstructured":"Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).","journal-title":"Genome Biol."},{"key":"8066_CR39","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/bioinformatics\/btz625","volume":"36","author":"K Polanski","year":"2020","unstructured":"Polanski, K. et al. BBKNN: fast batch alignment of single cell transcriptomes. Bioinformatics 36, 964\u2013965 (2020).","journal-title":"Bioinformatics"},{"key":"8066_CR40","unstructured":"Park, J. E. et al. A cell atlas of human thymic development defines T cell repertoire formation. Science 367, eaay3224 (2020)."},{"key":"8066_CR41","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1016\/j.csbj.2021.06.043","volume":"19","author":"M Andreatta","year":"2021","unstructured":"Andreatta, M. & Carmona, S. J. UCell: robust and scalable single-cell gene signature scoring. Comput. Struct. Biotechnol. J. 19, 3796\u20133798 (2021).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"8066_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25960-2","volume":"12","author":"JW Squair","year":"2021","unstructured":"Squair, J. W. et al. Confronting false discoveries in single-cell differential expression. Nat. Commun. 12, 5692 (2021).","journal-title":"Nat. Commun."},{"key":"8066_CR43","doi-asserted-by":"publisher","first-page":"W130","DOI":"10.1093\/nar\/gkx356","volume":"45","author":"J Wang","year":"2017","unstructured":"Wang, J., Vasaikar, S., Shi, Z., Greer, M. & Zhang, B. WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit. Nucleic Acids Res. 45, W130\u2013W137 (2017).","journal-title":"Nucleic Acids Res."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08066-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08066-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08066-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:56:28Z","timestamp":1746186988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08066-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8066"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-08066-z","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"assertion":[{"value":"17 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"690"}}